Shenzhen Rivaroxaban Co.,Ltd
Home
About us
Products
Rivaroxaban
Pharmaceutical Intermediates
Tegprazan
VeMurafenib
Anti-diabetic
Antiviral Drug
Antidepressants
Anti-cancer Drugs
High Polymer Materials
Complementary Medicines
Cardiovascular Medications
News
Blog
Contact us
Language
English
Home
>
Blog
LATEST NEWS
Covid vaccines and antivirals are not enough
People With Liver Disease Can Now Take Remdesivir for COVID
How to Prevent RSV in Adults and Children
Hyundai Bioscience to develop antiviral drug with NIH
Hyundai Bioscience to develop antiviral drug with U.S. NIH
Jul 31, 2023
Covid vaccines and antivirals are not enough
read more
Jul 30, 2023
People With Liver Disease Can Now Take Remdesivir for COVID
read more
Jul 29, 2023
How to Prevent RSV in Adults and Children
read more
Jul 28, 2023
Hyundai Bioscience to develop antiviral drug with NIH
read more
Jul 27, 2023
Hyundai Bioscience to develop antiviral drug with U.S. NIH
read more
Jul 26, 2023
AI and Optics Speed Up Virus Detection
read more
Jul 25, 2023
Researchers Are Testing Paxlovid as a Treatment for Long COVID
read more
Jul 24, 2023
Walmart, other drug stores want to help you skip trips to the doctor
read more
Jul 23, 2023
Bacteria exposed to antiviral drugs develop antibiotic cross
read more
Jul 22, 2023
A New Era of Antidepressants: Postpartum survivor speaks on new FDA
read more
Jul 21, 2023
Respiratory Viral Infections The Next Frontier For Antiviral Drug Development
read more
Jul 20, 2023
The Phase 1a/1b Human Clinical Trial of NV
read more
first
1
2
3
4
5
6
7
last